Makoto Shimazaki

The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease

Masahide Hamaguchi, Takao Kojima, Noriyuki Takeda et al. · Annals of Internal Medicine · 2005 · 1.1K citations

Discovery of novel and selective IKK-β serine-threonine protein kinase inhibitors. Part 1

Toshiki Murata, Mitsuyuki Shimada, Sachiko Sakakibara et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 171 citations · Full text

Molecular Pharmacology, Drug Target, Medicine +8

An Orally Bioavailable Small Molecule Antagonist of CRTH2, Ramatroban (BAY u3405), Inhibits Prostaglandin D2-Induced Eosinophil Migration in Vitro

Hiromi Sugimoto, Michitaka Shichijo, Takashi Iino et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 159 citations

Synergistic Inhibition of Human α-1,3-Fucosyltransferase V

Lei Qiao, Brion W. Murray, Makoto Shimazaki et al. · Journal of the American Chemical Society · 1996 · 105 citations

Human α-1,3-Fucosyltransferase V, Biosynthesis, Engineering +14

Synthesis of Sialyl Lewis X Mimetics and Related Structures Using the Glycosyl Phosphite Methodology and Evaluation of E-Selectin Inhibition

Chun‐Cheng Lin, Makoto Shimazaki, Marie‐Pierre Heck et al. · Journal of the American Chemical Society · 1996 · 90 citations

Bioorganic Chemistry, Glycobiology, Glycosylation Reactions +18